Silvana Sandri Selected Research

Interleukin-10 (Interleukin 10)

1/2017

Role of poly(ε-caprolactone) lipid-core nanocapsules on melanoma-neutrophil crosstalk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvana Sandri Research Topics

Disease

5	Neoplasms (Cancer) 12/2023 - 01/2016
5	Melanoma (Melanoma, Malignant) 12/2023 - 01/2016
4	Inflammation (Inflammations) 01/2024 - 05/2008
3	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2016
3	Insulin Resistance 03/2022 - 02/2015
2	Colitis 01/2024 - 01/2021
2	Weight Gain 03/2022 - 01/2016
2	Hypoxia (Hypoxemia) 01/2019 - 10/2013
2	Fibrosis (Cirrhosis) 01/2018 - 01/2018
1	Body Weight (Weight, Body) 03/2022
1	Endotoxemia 03/2022
1	Atherosclerosis 02/2021
1	Atherosclerotic Plaque (Atheroma) 02/2021
1	Peritonitis 01/2021
1	Burns 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Herpes Zoster 11/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2020
1	Uterine Cervical Dysplasia 09/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2020
1	Lung Diseases (Lung Disease) 01/2018
1	Obesity 01/2016
1	Acute-Phase Reaction 01/2014
1	Necrosis 12/2011
1	Experimental Diabetes Mellitus 06/2010
1	Renal Insufficiency (Renal Failure) 06/2010
1	Infections 05/2008

Drug/Important Bio-Agent (IBA)

4	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2022 - 05/2008
4	Messenger RNA (mRNA)IBA 03/2022 - 10/2013
3	Annexin A1IBA 01/2023 - 09/2020
3	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 02/2015
3	Proteins (Proteins, Gene)FDA Link 09/2020 - 10/2013
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
2	LipopolysaccharidesIBA 01/2021 - 01/2016
2	Phosphates (Orthophosphate)IBA 01/2021 - 06/2010
2	Therapeutic UsesIBA 01/2020 - 01/2019
2	NanocapsulesIBA 01/2019 - 01/2017
2	LipidsIBA 01/2019 - 01/2017
2	caprolactoneIBA 01/2019 - 01/2017
2	ParaquatIBA 01/2018 - 01/2018
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2024
1	Dextrans (Dextran)FDA Link 01/2024
1	decabromobiphenyl ether (decabromodiphenyl ether)IBA 12/2023
1	LeptinIBA 03/2022
1	Insulin (Novolin)FDA Link 03/2022
1	Docosahexaenoic AcidsIBA 02/2021
1	BuffersIBA 01/2021
1	SmokeIBA 01/2021
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021
1	Infliximab (Remicade)FDA Link 01/2021
1	Dextran SulfateIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 11/2020
1	Claudin-1IBA 11/2020
1	Mucin-1 (CA 15-3 Antigen)IBA 11/2020
1	Cisplatin (Platino)FDA LinkGeneric 09/2020
1	DNA (Deoxyribonucleic Acid)IBA 09/2020
1	Peptides (Polypeptides)IBA 09/2020
1	DNA AdductsIBA 09/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020
1	Drug CarriersIBA 01/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2018
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2017
1	acetyleugenolIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Antisense OligonucleotidesIBA 01/2016
1	matrigelIBA 01/2016
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2016
1	VemurafenibIBA 01/2016
1	Matrix Metalloproteinase InhibitorsIBA 01/2016
1	Amyloid (Amyloid Fibrils)IBA 10/2013
1	Lipoproteins (Lipoprotein)IBA 12/2011
1	IronIBA 06/2010
1	Phosphorus (Red Phosphorus)IBA 06/2010
1	ChitosanIBA 06/2010
1	AlloxanIBA 06/2010
1	PolymersIBA 06/2010
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 05/2008

Therapy/Procedure

5	Therapeutics 02/2021 - 01/2017
1	Oral Administration 01/2024
1	Drug Therapy (Chemotherapy) 09/2020
1	Aftercare (After-Treatment) 01/2016